Overall, recent studies have demonstrated that increasing systemic levels of PF4 in the cerebrovasculature could ameliorate age-related neurodegeneration and cognitive impairment in a hippocampal neurogenesis-dependent manner. The gene discussed is PF4; the disease is Cognitive impairment.